Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
HRTX
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w low +21.8%
HRTX
Heron Therapeutics, Inc.
☁️ News word cloud
Top words across the last 50 articles for this ticker.
therapeutics
heron
nasdaq
after
study
data
revenue
drug
treatment
million
expected
stage
patients
here
estimates
gained
results
cancer
therapy
rare
StonvexStonvexStonvexStonvex